Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Feasibility trial of high-dose versus standard-dose quadrivalent influenza vaccine in Danish adults aged 65-79 years
2021-003170-31Phase 2Completed
- Sponsor
- Cardiovascular Non-Invasive Imaging Research Laboratory, Department of Cardiology, Herlev and Gentofte Hospital
- Start
- Jun 2021
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of quadrivalent influenza vaccine in influenza (2 arms), sponsored by Cardiovascular Non-Invasive Imaging Research Laboratory, Department of Cardiology, Herlev and Gentofte Hospital. Primary endpoint: Feasibility of identification, recruitment, and randomization. Started Jun 2021; status: completed.
02
Drugs
quadrivalent influenza vaccine
03
Conditions
influenza
Beyond the preview
Go deeper on 2021-003170-31.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2021-003170-31.